Fushine Biotechnology is a majority-owned subsidiary of Fushine Pharmaceutical Co., Ltd.
We are dedicated to redefining global nutrition through our innovative FuNext mycoprotein solutions. Driven by sustainability and advanced biotechnology, we develop clean, high-quality food ingredients designed to meet the evolving global demand for proteins.
Shaping the Future
S
Our S-Framework of Mycoproteins
Transforming Modern Lifestyles
Smart
Intelligent
Advanced bio-synthesis technologies that enable innovative food applications and new lifestyle possibilities.
Sustainable
Sustainable
Low-carbon, ESG-aligned, and natural food resources that support long-term planetary health.
Space
Cosmic
Space-ready and future-focused foods designed to sustain human life in extreme environments and inspire the next era of nutrition.
LEADER IN S-GENERATION PROTEIN
Our Steps
Our Steps
2023/4
Fushine launched its mycoprotein initiative, developed through independent research and strengthened by international collaboration.
2023/9
We completed a pilot production line with an annual capacity of 1,200 tons of mycoprotein.
2024/9
We were granted the invention patent certificate for "Application of Fusarium venenatum in the Production of Mycoprotein," issued by the State Intellectual Property Office.
2024/11
Our mycoprotein was selected as one of the Top Ten Advances in China Food Science and Technology 2024.
2025/1
Fushine was recognized as an exemplary Science and Technology Innovation case. At the same time, its FuNext Mycoprotein brand achieved U.S. GRAS certification, becoming one of the few Chinese companies authorized to enter the U.S. market.
2025/9
Fushine announced the establishment of the FuNext Protein Business Alliance in Shanghai.
2023/4
2023/9
2024/9
2024/11
2025/1
2025/9
Efficient Operations Sustainable Futures
Efficient Operations Sustainable Futures
FuNext has completed a 1,200-ton mycoprotein production line, making a major step toward scaled, sustainable manufacturing.
In the near future, we expect to reach an annual output of 20,000 tons of mycoprotein, alongside an annual production capacity of 50,000 tons of amino-acid-based water-soluble fertilizer.